An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis
Background: Atopic dermatitis (AD), a chronic recurrent inflammatory skin condition primarily affects children. Topical treatment, systemic treatment, and phototherapy are mainstay of treatment. Objectives: Topical corticosteroids (TCS) are the first line therapy for AD but are associated with v...
Guardado en:
Autores principales: | Vinodhini R. Mudaliyar, Asha Pathak, Alok Dixit, Sweta Kumar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Mattioli1885
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/70fba1fbb75742c4ba50fdd3406297b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France
por: Angèle Soria, et al.
Publicado: (2021) -
Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study
por: P. Kiruba Shankari, et al.
Publicado: (2021) -
Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose
por: Yu K, et al.
Publicado: (2017) -
Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects
por: Wang Y, et al.
Publicado: (2019) -
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi JH, et al.
Publicado: (2021)